The Korea Times
Celltrion said Tuesday it acquired French health care firm Gifrer, securing a sales network capable of responding swiftly to changes in local health care policies. According to the Korean biopharmaceutical firm, its French unit acquired the entire stake in Gifrer. The two sides did not disclose the financial details of the deal, but said they plan to finalize administrative procedures related to the acquisition by the end of this month. Celltrion said it will operate Gifrer as an independent entity and retain the employment of around 70 employees working at the French firm. Established in 1912, Gifrer is a small company but holds a sales network spanning more than 9,000 pharmacies and about 800 hospitals across France. It also holds a meaningful market presence in local over-the-counter products, including physiological saline solution, tooth whitening products, infant care products and other drugstore medicines. The acquisition marks Celltrion’s strategic move aimed at leveraging Gifrer’s local sales network. Through the deal, the company secured pharmacy sales capabilities tailored
Go to News Site